Joseph M. Busky - 28 Mar 2026 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 Mar 2026, 16:14:00 UTC
Prior SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip S. Askim, attorney-in-fact for Joseph M. Busky

Key filing fact

Joseph M. Busky filed Form 4 for QuidelOrtho Corp (QDEL) on 31 Mar 2026.

Key facts

  • This page summarizes Joseph M. Busky's Form 4 filing for QuidelOrtho Corp (QDEL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 31 Mar 2026, 16:14.

Change

  • Previous filing in this sequence was filed on 19 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001385091 Primary reporting owner

Busky Joseph M.

Relationship
Chief Financial Officer
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO
Signature
/s/ Phillip S. Askim, attorney-in-fact for Joseph M. Busky
Signature date
31 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Award

Transaction value
Shares
+4,925
Change %
+12%
Price
$0.000000*
Shares after
46,337
Date
28 Mar 2026
Ownership
Direct
Footnotes
F1
QDEL transaction

Common Stock

Tax liability

Transaction value
Shares
-1,519
Change %
-3.3%
Price
$14.78*
Shares after
44,818
Date
28 Mar 2026
Ownership
Direct
Footnotes
F2
QDEL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,290
Date
28 Mar 2026
Ownership
By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-4,925
Change %
-100%
Price
$0.000000*
Shares after
0
Date
28 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,925
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects release of restricted stock units that were previously reported on a Form 4.

Footnote F2

Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

Footnote F3

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F4

14,775 shares vested in equal installments on March 28, 2024, March 28, 2025 and March 28, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .